Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details)

v3.21.1
Stockholders' Equity (Details) - USD ($)
1 Months Ended 12 Months Ended
Sep. 10, 2020
May 12, 2020
Apr. 14, 2020
Mar. 12, 2020
Jan. 08, 2020
Dec. 11, 2019
Dec. 05, 2019
Nov. 11, 2019
Sep. 09, 2019
Feb. 13, 2019
Oct. 31, 2020
Aug. 31, 2020
Aug. 27, 2020
Aug. 25, 2020
Jun. 24, 2020
May 31, 2020
Apr. 30, 2020
Apr. 21, 2020
Apr. 16, 2020
Apr. 15, 2020
Feb. 29, 2020
Jan. 31, 2020
Dec. 23, 2019
Nov. 20, 2019
Sep. 30, 2019
Sep. 25, 2019
Sep. 16, 2019
Jul. 17, 2019
Jun. 28, 2019
Jan. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Jan. 30, 2019
Dec. 19, 2018
Stockholders’ Equity (Textual)                                                                    
Common stock, shares authorized                                                             45,000,000 45,000,000    
Common stock per share (in Dollars per share)                                     $ 6.95                       $ 0.001 $ 0.001    
Value of common stock shares issued (in Dollars)                                     $ 36,584.80                       $ 9,896 $ 7,391    
Number of shares issued                                     5,264                       9,895,600 7,390,261    
Settling of accrued expenses (in Dollars)                           $ 125,000                                        
Gain loss on settlement of accounts payable (in Dollars) $ 717,450                       $ 7,990 $ 17,226                                        
Transfer of common stock to consultants, description                                                             On or about February 1, 2019, the Company’s founder and CEO as well as another shareholder transferred an aggregate of approximately 1,379,000 and 144,000 shares of common stock, respectively to certain consultants of the Company, of which approximately 983,000 and 144,000 shares of common stock, respectively were sold to consultants in exchange for promissory notes. The Company accounted for these share transfers as stock-based compensation expense based upon the Black-Scholes model as if these were stock option grants made by the Company. The Company used the following inputs in the Black-Scholes option pricing model, expected life of 5 years, risk-free interest rate of 2.51%, volatility 92% and dividend yield of 0%. As a result, the Company recognized approximately $3.6 million of stock-based compensation expense during the first quarter of 2019 related to these share transfers. Additionally, approximately 396,000 shares of common stock were transferred by the founder and CEO to contractors for no consideration. The Company accounted for these share transfers as stock-based compensation based upon the underlying common stock price of $4.37 as of the date of transfer. The Company recognized approximately $1.7 million of stock-based compensation expense related to these transfers during the first quarter of 2019.      
Cash payment (in Dollars)                                                               $ 5,884,361    
Issuance of shares of accounts payable   104,567                                 100,000                     1,401        
Issuance of value of accounts payable (in Dollars)   $ 93,150                                 $ 640,517                              
Fair value of per share (in Dollars per share)   $ 5.76                                 $ 6.95                              
Recorded a loss on settlement (in Dollars)   $ 509,160                                                                
Warrants to purchase shares of common stock, description                             the Company issued 80,000 shares of common stock and warrants to purchase 100,000 shares of common stock, of which 50,000 shall be exercisable at $3.80 per share and the remaining 50,000 shall be exercisable at $5.80 per share, in each case for a term of 5 years, in connection with the termination of a consulting arrangement and in full settlement of any and all claims again the Company. The Company had previously accrued $195,000 in connection with this consulting arrangement. The stock had a fair value of $2.37 per share.                                      
Shares of common stock in full settlement of accounts payable 140,000                       17,000                                          
Value of common stock in full settlement of accounts payable (in Dollars) $ 806,400                       $ 40,800                                          
Full settlement of accounts payable (in Dollars) $ 88,950                       $ 48,790                                          
Fair value of per shares (in Dollars per share) $ 5.76                       $ 2.20                                          
Issuance of common stock (in Dollars)                                                             $ 36,842      
Sale of stock, consideration received (in Dollars)                               $ 515,000                                    
Sale of stock, committed (in Dollars)                               $ 565,000                                    
Sale of stock, shares                               135,527                                    
Common stock, per share (in Dollars per share)                               $ 3.80                                    
Warrants to purchase of shares                               169,409                                    
Warrants exercise price (in Dollars per share)                               $ 4.00                                    
Shares issued for equity financing (in Dollars)                                                             140,000      
Equity financing current liabilities (in Dollars)                                                             375,000    
Shares, Issued                                                                 3,000,000  
Stockholders’ equity description             the Company issued 50,000 RSU’s to a member of the board of directors. The RSU’s vested immediately and had a fair value of $135,000. Additionally, on December 10, 2019, the board of directors awarded stock options under the 2016 Plan to each of the three remaining independent directors to 50,000 shares of the Company’s common stock. The stock options have a term of five years, an exercise price of $2.64 per share, vest immediately on the grant date of December 10, 2019 and had a grant date fair value of $388,746. The Company determined the fair value of the stock options using the Black-Scholes model with the following inputs: expected life 10 years, risk-free interest rate 1.0%, dividend yield 0% and expected volatility 100%.     the Board of Directors of the Company granted an aggregate of 425,000 restricted stock units (“RSUs”) under the 2016 Plan, of which an aggregate of 325,000 shares were granted to management and vest quarterly over the next three years, and of which 100,000 were issued to a consultant and vest quarterly over one year. Upon the effectiveness under the Securities Act of a registration statement on Form S-8 with respect to the shares covered by the 2016 Plan, these RSUs vest in twelve equal quarterly instalments, commencing on the grant date of February 13, 2019 and had a grant date fair value of approximately $2.7 million. The Company also granted an additional 525,000 RSUs which are subject to performance vesting, of which an aggregate of 225,000 shares were issued to management and 300,000 were issued to a consultant. The 225,000 shares issued to management were cancelled in April 2020, when the person’s employment with the Company terminated. Additionally, the board of directors awarded stock options under the 2016 Plan to each of the four independent board members to acquire an aggregate of 53,572 shares of the Company’s common stock and to an employee to acquire 25,000 shares. The stock options have a term of five years, an exercise price of $6.49 per share, vest quarterly over four quarters beginning on the grant date of February 13, 2019 and had a grant date fair value of $431,000. The Company determined the fair value of the stock options using the Black-Scholes model with the following inputs: expected life 10 years, risk-free interest rate 0.25%, dividend yield 0% and expected volatility 90%.                                                
Stock-based compensation expense (in Dollars)                                                         $ 162,250          
Unrecognized expense for unvested stock options and restricted stock awards (in Dollars)                                                             $ 2,500,000 $ 3,200,000    
RSU [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Shares issued to employee                   250,000                                                
Warrant [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Common stock per share (in Dollars per share)                                                             $ 4.00      
Cashless exercise of common stock warrants, Shares                       116,448       56,982 520,925                                  
Purchase of warrants shares                                                             46,053      
Prior receipt equity financing (in Dollars)                                                             $ 140,000      
Common Stock [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Warrants exercised                                                               1,283,124    
Cash payment (in Dollars)                                                               $ 1,283    
Cashless exercise of common stock warrants, Shares                       68,715       26,034 321,155                                  
Common stock option exercised                       28,890         57,534                                  
Shares issued for equity financing (in Dollars)                                                             $ 38      
Common Stock [Member] | Equity Option [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Common stock option exercised                       55,263         105,028                                  
Former Employee [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Shares issued         50,000                                     25,000                    
Shares issued to employee                           87,255 25,000     30,303             24,843                  
Value issued to employee (in Dollars)                           $ 142,226                   $ 73,250 $ 75,000                  
Director [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Shares issued             50,000                                                      
Value of common stock shares issued (in Dollars)             $ 135,000                                                      
Employee [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Shares issued to employee       16,667                               3,913                            
Series A Convertible Preferred Stock [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Shares issued           6,579   200,000 200,000   13,158 13,158       51,316 1,043,935       172,369 5,264 9,211     73,156 43,081 65,789            
Conversion of shares                 76,000   5,000 5,000       19,500 396,695       65,500 2,000         16,371 25,000            
Stock conversion, description                                                     On September 16, 2019, we issued 108,422 shares of our common stock to a holder of our shares of Series A Convertible Preferred Stock upon the conversion of 41,200 of such shares of Series A Convertible Preferred Stock.              
Value of common stock shares issued (in Dollars)           $ 21,053   $ 584,000                             $ 26,343     $ 250,000                
Common Stock [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Warrants exercised     7,000                                                              
Cash payment (in Dollars)     $ 38,570                                                              
Series A Preferred Shares [Member]                                                                    
Stockholders’ Equity (Textual)                                                                    
Preferred stock, shares authorized                                                             900,000 900,000   900,000
Preferred stock, par value (in Dollars per share)                                                             $ 0.001 $ 0.001   $ 0.001